Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07459244) titled 'ECG Findings in Methamphetamine Use' on March 4.

Study Type: Observational

Primary Sponsor: Elazig Mental Health and Diseases Hospital

Condition: Methamphetamine Use Disorder Methamphetamine Induced Psychosis

Recruitment Status: Recruiting

Date of First Enrollment: April 7, 2025

Target Sample Size: 240

Countries of Recruitment: Turkey (Turkiye)

To know more, visit https://clinicaltrials.gov/study/NCT07459244

Disclaimer: Curated by HT Syndication....